New research into COVID-19 has revealed some troubling findings. Even mild cases can lead to lasting heart complications.
Comparing test data collected before and after a group of patients in their mid-30s contracted mild cases of COVID, researchers noticed an increase in arterial stiffness and cardiovascular inflammation. That means they may face “a widespread and long-lasting pathological process” that places them at elevated risk of cardiovascular issues.
Heart disease is already America’s leading cause of death, claiming roughly 700,000 lives per year. Add to that potentially increased risk among the millions and millions of Americans who have had COVID, and the need for more investment in the research and development of novel drugs is clear.